New generation Cryoballoon: 1st in Africa and Middle East at the CTAFC

14th May 2019

The CTAFC is gearing to launch the new generation Cryoballoon in the Middle East and Africa region.

Cape Town will be the 1st city outside the USA and Europe to use the new technology in the treatment of AF, and the CTAFC the 1st unit outside the USA and Europe to implement the new technology as part of their armour to effectively treat AF.

The Arctic Front Advance Pro™ Is Medtronic’s 4th generation Cryoballoon.  It was first made available in Europe in October 2018 and will be launched globally starting in 2019.

-Arctic Front Advance Pro was designed to improve visualization of time-to-isolation and to improve maneuverability in patients with smaller left atria or early pulmonary vein branching.  It is based on the proven Arctic Front platform, which has been studied in over 700 peer-reviewed articles and abstracts.  For more information, please see attached materials.

-Medtronic plc, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.